Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Remedica Ltd, Aharnon Str, Limassol Industrial Estate, 3056 Limassol, Cyprus
Monorem R 60 mg prolonged-release tablets.
| Pharmaceutical Form |
|---|
|
Prolonged-release tablet. White, oval tablets, scored on both sides and embossed with R/R on one side. The tablet can be divided into equal doses. |
Each prolonged-release tablet contains diluted isosorbide mononitrate equivalent to 60 mg isosorbide mononitrate.
Excipient(s) with known effect:
This product contains 215 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Isosorbide mononitrate |
Isosorbide mononitrate is an organic nitrate, which, in common with other cardioactive nitrates, is a vasodilator. It produces decreased left and right ventricular end-diastolic pressures to a greater extent than the decrease in systemic arterial pressure, thereby reducing afterload and especially the preload of the heart. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Aluminium/PVC blisters. Pack sizes of 30 and 100 prolonged-release tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str, Limassol Industrial Estate, 3056 Limassol, Cyprus
21764
Date of first authorization: 27 May 2013
Date of latest renewal: 03 March 2020
| Drug | Countries | |
|---|---|---|
| MONOREM | Cyprus, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
